| 期刊全称 | Antirheumatic Therapy: Actions and Outcomes | | 影响因子2023 | Richard O. Day,Daniel E. Fürst,Barry Bresnihan | | 视频video | | | 发行地址 | Comprehensive and well structured according to classes of agents.Includes an outlook on future molecular targets.International authorship | | 学科分类 | Progress in Inflammation Research | | 图书封面 |  | | 影响因子 | Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian‘s opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2) | | Pindex | Book 2005 |
The information of publication is updating
|
|
发表于 2025-3-21 18:01:21
